MedPath

Dextech Medical AB

Dextech Medical AB logo
🇸🇪Sweden
Ownership
Public
Established
2004-01-01
Employees
11
Market Cap
-
Website
http://www.dextechmedical.com

Clinical Trials

11

Active:6
Completed:2

Trial Phases

2 Phases

Phase 1:8
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (72.7%)
Phase 2
2 (18.2%)
phase_1_2
1 (9.1%)

Study of ODX (OsteoDex) in Multiple Myeloma

Phase 1
Recruiting
Conditions
Multiple Myeloma
Interventions
Drug: ODX (Osteodex)
First Posted Date
2024-09-27
Last Posted Date
2025-08-19
Lead Sponsor
DexTech Medical AB
Target Recruit Count
12
Registration Number
NCT06616389
Locations
🇸🇪

Karolinska Universitetssjukhuset Huddinge Cancerstudieenheten M62, Stockholm, Sweden

🇸🇪

Uddevalla Sjukhus, Hematologens dagvård, Uddevalla, Sweden

Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Phase 2
Completed
Conditions
Prostate Cancer Metastatic
Interventions
First Posted Date
2016-07-07
Last Posted Date
2024-08-29
Lead Sponsor
DexTech Medical AB
Target Recruit Count
55
Registration Number
NCT02825628
Locations
🇪🇪

East Tallinn Central Hospital, Tallinn, Estonia

🇪🇪

Tartu University Hospital, Tartu, Estonia

🇫🇮

Tampere University Hospital, Urology Clinic, Tampere, Finland

and more 5 locations

A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC

Phase 2
Terminated
Conditions
Prostate Cancer Metastatic
Interventions
Drug: Placebo
First Posted Date
2015-03-04
Last Posted Date
2016-06-30
Lead Sponsor
DexTech Medical AB
Target Recruit Count
3
Registration Number
NCT02378870
Locations
🇸🇪

Oncology clinic, Norrlands Universitetssjukhus, Umeå, Sweden

A Phase I/II Study of ODX (Osteodex) in Metastatic Castration Resistant Prostate Cancer (CRPC)

Phase 1
Completed
Conditions
Prostate Cancer Metastatic
Interventions
First Posted Date
2012-05-09
Last Posted Date
2014-11-14
Lead Sponsor
DexTech Medical AB
Target Recruit Count
28
Registration Number
NCT01595087
Locations
🇸🇪

Oncology clinic, Skånes Universitetssjukhus i Lund, Lund, Sweden

🇸🇪

Urology clinic, Södersjukhuset AB, Stockholm, Sweden

🇸🇪

Oncology clinic, Norrlands Universitetssjukhus, Umeå, Sweden

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.